IVD Raw Materials
Learn the applications of neoantigen peptides as personalized Cancer Vaccine (PCV), solid tumor immuno-therapy, and the solutions for neoantigen production, through GenScript’s proprietary technologies, for precision immunotherapy development.
12-07-2022 Gracie Chia, Field Application Scientist, GenScript
09-19-2022 Dr. Fengmei Pi, Head of RNA Biology Department, GenScript
Target identification in solid tumors can help enable therapeutic development against indications of high unmet need and across a wide patient population.
10-07-2020 Marvin Gee, Ph.D. Co-Founder and Head of Target Discovery
Neoantigen based immuno-oncology therapies are proving promising, but neoantigen identification and production are bottlenecks to boosting efficacy.
09-10-2020 Raymond Miller, Ph.D., GenScript. Julie Rumble Ph.D., Cayman Chemical